IHL 0.00% 4.1¢ incannex healthcare limited

Ann: IHL initiates psilocybin clinical trial for anxiety disorder, page-31

  1. 122 Posts.
    lightbulb Created with Sketch. 115
    This board just continually delivers. This is unbelievable, I knew it would be good but this has blown my mind.
    What amazing partnerships, FDA meetings upcoming, world first of its kind, extensive trial with large number of patients in a field of medicine that desperately needs successful treatments. I have friends who struggle with anxiety frequently and a successful trial like this would change peoples lives.
    Market open for one hour and we've had 15 million shares sold and we all know how tightly held this register is. 20c later today or at latest by the end of this week. The potential this has created for us is mind bobbling. I can't even fathom why anyone would be selling even one share at the moment.
    Well done to all of us who got in early. This company still continues to fly under the radar but I think the masses are finally beginning to wake up to the exceptional management we have and the huge development pipeline they have created.
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.